Headlands Technologies’s Vir Biotechnology VIR Stock Holding History

Headlands Technologies’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$655K	Sell	64,299 -38,948	-38%	-$371K	0.07%	347
2026 Q1	$925K	Buy	103,247 +80,691	+358%	+$643K	0.11%	221
2025 Q4	$136K	Buy	+22,556	New	+$134K	0.01%	616
2025 Q3	–	Sell	-1,573	Closed	-$7.93K	–	1277
2025 Q2	$7.93K	Sell	1,573 -26,518	-94%	-$142K	﹤0.01%	1035
2025 Q1	$182K	Sell	28,091 -4,341	-13%	-$38.6K	0.02%	472
2024 Q4	$238K	Buy	32,432 +20,984	+183%	+$166K	0.02%	489
2024 Q3	$85.7K	Sell	11,448 -20,841	-65%	-$181K	0.01%	701
2024 Q2	$287K	Buy	32,289 +20,556	+175%	+$197K	0.03%	390
2024 Q1	$119K	Buy	+11,733	New	+$119K	0.03%	505

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Headlands Technologies's VIR Position: Q2 2026 in Review

Headlands Technologies reduced its Vir Biotechnology (VIR) stake by 38% in Q2 2026, selling an estimated $371K and leaving 64,299 shares worth $655K. The position accounts for 0.07% of the portfolio, ranked #347.

Headlands Technologies first reported a position in VIR in Q1 2024 and has held it in 9 quarters since. The position peaked at $925K in Q1 2026. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

Headlands Technologies held 64,299 shares of Vir Biotechnology worth $655K as of Q2 2026.
Headlands Technologies sold 38,948 Vir Biotechnology shares in Q2 2026, an estimated $371K.
Vir Biotechnology made up 0.07% of Headlands Technologies's portfolio in Q2 2026, its #347 holding.
Headlands Technologies first reported a position in Vir Biotechnology in Q1 2024 and has held it in 9 quarters since.
Headlands Technologies's Vir Biotechnology position peaked at $925K in Q1 2026.
237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.